Francois Nader

Type: Person
Name: Francois Nader
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

NPS Pharma Releases Second-Quarter 2014 Financial Results

NPS Pharmaceuticals reported its results for the quarter ended June 30. In its release on August 6, NPS Pharma reported net global Gattex/Revestive sales of $22.0 million for the second quarter of 2014, compared to $4.8 million for the same period last ... [Published Individual.com - Aug 11 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q2 2014 Results - Earnings Call Transcript

OperatorGood day, ladies and gentlemen, and welcome to the NPS Pharmaceuticals Second Quarter 2014 Financial Result Conference Call. My name is [Estobon] (ph) and I will be your operator for today. At this time, all participants are in listen-only-mode. ... [Published Seeking Alpha - Aug 07 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

NPS Pharmaceuticals reported first-quarter net sales of Gattex totaling $17.9 million, a consensus miss which the company blames on bad winter weather and a rise in the number of patients discontinuing therapy. The slow start to the year means NPS Pharma ... [Published The Street Latest - May 08 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Clementia Pharmaceuticals Inc. Appoints Francois Nader, M.D. to Board of Directors

Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ... [Published Marketwire - Breaking News Releases - Mar 26 2014]

More Content

All (5) | News (4) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NPS Pharma Releases Second-Quarter 2014 Financi... [Published Individual.com - Aug 11 2014]
NPS Pharmaceuticals' (NPSP) CEO Francois Nader ... [Published Seeking Alpha - Aug 07 2014]
NPS Pharma Blames Winter, Drug Stops for Weak F... [Published The Street Latest - May 08 2014]
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
NPS Pharma's hypoparathyroidism drug Natpara ge... [Published PharmaBiz - Jan 07 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.